Skip to main content
Figure 1 | BMC Public Health

Figure 1

From: Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Figure 1

Overview of the cohort model. NoHPVonc: Women in this health state have no oncogenic HPV infection. HPVlr: Women in this health state have a low risk (non-oncogenic) HPV infection. HPVonc: Women in this health state have an oncogenic HPV infection. CIN1onc: Women in this health state have developed cervical intraepithelial neoplasia (CIN)1 due to an infection with an oncogenic HPV type. Wart: Women in this health state have genital warts. CIN1lr: Women in this health state have developed CIN1 due to an infection with a low risk HPV type. CIN23: Women in this health state have developed CIN2/3 due to an infection with an oncogenic HPV type. Det: represents women within each of the health states whose cervical disease is detected through screening.

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us